Recovery Management Checkup Scalability and Sustainability Hybrid Experiment
Public ClinicalTrials.gov record NCT07873944. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Recovery Management Checkup Scalability and Sustainability (RMC-SS) Hybrid Experiment: Evaluating Comparability of Client and Implementation Outcomes in Community Organizations Post-Arrest
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Individuals who are involved in the criminal-legal system (CLS) are at high risk of drug-related overdose; they also face significant barriers to engaging in substance use disorder (SUD) treatment and recovery support services. To address this public health challenge, this study will test the implementation and outcomes of an evidence-based intervention, Recovery Management Check-ups (RMC), delivered within community-based programs in four Chicago communities that have high rates of drug-related overdose and arrests. The study has the potential to increase uptake of RMC in community-based programs, thereby reducing overdose-related deaths and crime-related costs and improving individual health and community public health.
Study identification
- NCT ID
- NCT07873944
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 600 participants
Conditions and interventions
Conditions
Interventions
- Recovery Management Checkups (RMC) delivered by community-based agencies (RMC adopters) Behavioral
- Recovery Management Checkups (RMC) delivered by staff under the research team (RMC by research staff) Behavioral
Behavioral
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2, 2026 (Estimated)
- Primary completion
- Apr 30, 2029 (Estimated)
- Completion
- Apr 30, 2029 (Estimated)
- Last update posted
- Oct 14, 2026
2026 – 2029
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Chestnut Health Systems Lighthouse Institute | Chicago | Illinois | 60610 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07873944, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 14, 2026 · Synced Oct 14, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07873944 live on ClinicalTrials.gov.